Trial intelligence / Profile preview

Bemiparin versus unfractionated calcium heparin as perioperative bridging therapy in anticoagulated patients undergoing ambulatory or short-stay surgery

2006-001862-17Phase 3Active

Sponsor
Hospital de la Santa Creu i Sant Pau Research Institute
Start
Mar 2010
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in thromboembolism and Phlebothrombosis comparing Bemiparin bridging therapy with Calcium heparin bridging therapy (2 arms). Primary endpoint: Occurrence of thromboembolic events. Started Mar 2010; status: active.

02

Drugs

bemiparinheparin
03

Conditions

thromboembolismPhlebothrombosis

Beyond the preview

Go deeper on 2006-001862-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001862-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call